I believe the individual health insurance mandate contained in the Patient Protection and Affordable Care Act represents a significant overreach by the federal government. It is also fiscally irresponsible. The new taxes and burdensome regulations in this law are driving the cost of healthcare even higher for working families, and straining our healthcare providers and small businesses.
I support reforming healthcare with market-based solutions to empower patients and doctors, and malpractice reforms to protect consumers and provide incentives for best medical practices.
More on Health Issues
Recording: Download Audio
WASHINGTON, D.C. – Congressman Kevin Cramer voted for legislation passed today in the House of Representatives increasing access to experimental drugs for patients with terminal illnesses.
WASHINGTON, D.C. – Congressman Kevin Cramer made the following comments after the release of an oversight report by the House Energy and Commerce Committee into the 340B prescription drug program. The 340B Program, which was created in 1992, enables covered entities to use federal resources to reach more eligible patients and provide more comprehensive services. Covered entities can provide 340B drugs to patients regardless of income or insurance status and generate revenue by receiving reimbursement from patients insurance.